EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge Model

Bridgette Galafa iD, Tarsizio Chikaonda iD, Evaristar Kudowa, Simon Sichone iD, Lusako Sibale iD, Faith Thole, Christopher Mkandawire, Dingase Dula iD, Edna Nsomba iD, Godwin Tembo iD, Mphatso Chaponda, Anthony E Chirwa iD und 18 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiae341 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Bridgette Galafa und 29 weiteren Autor:innen. Beteiligte Einrichtung: Malawi Liverpool Wellcome Programme, Blantyre. Hauptthemen laut MEDLINE: Carrier State, Pneumococcal Vaccines, Streptococcus pneumoniae, Pneumococcal Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Liverpool School of Tropical Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Malawi, the national 13-valent pneumococcal conjugate vaccine (PCV13) demonstrated less herd immunity than in the United States, likely due to higher natural pneumococcal carriage rates. We assessed PCV13 efficacy against experimental pneumococcal carriage in healthy Malawian adults. We explored how natural carriage (pneumococcal carriage of any serotype apart from 6B) influenced experimental carriage rates and vaccine efficacy.

Methods

Healthy adults aged 18 to 40 years were randomly assigned to PCV13 (n = 98) or saline (n = 106), followed by intranasal SPN 6B inoculation at 20 000 (n = 40), 80 000 (n = 74), or 160 000 (n = 90) colony-forming units/100 µL at 28 days postvaccination. We evaluated natural and experimental pneumococcal carriage before and after vaccination on days 2, 7, and 14 postinoculation using culture and multiplex quantitative polymerase chain reaction (qPCR) targeting the lytA/cpsA genes, and we compared carriage rates by vaccination status.

Results

Of 204 participants, 19.6% (n = 40) exhibited experimental carriage detected by culture and 25.5% (n = 52) by qPCR. Vaccinated individuals had lower experimental carriage rates (10.2%, n = 10/98) than the placebo group (28.3%, 30/106). This difference in vaccine efficacy was more pronounced in participants without natural carriage (PCV13, 8%, 6/75; placebo, 25.9%, 21/81) vs those with natural carriage (PCV13, 14.8%, 4/27; placebo, 26.5%, 9/34). According to a log-binomial model, vaccine effectiveness (VE) was 62%, whether assessed by culture or qPCR. Natural carriers had lower VE (52%) vs participants with no natural carriage (69%).

Conclusions

We have shown that the PCV13 VE estimate (62%) is robust whether carriage is assessed by culture or qPCR. PCV13 had lower VE in natural carriers when compared with those without natural carriage at the inoculation visit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carrier StatePneumococcal VaccinesStreptococcus pneumoniaePneumococcal InfectionsVaccine EfficacyHumansAdultMaleFemaleYoung AdultAdolescentVaccines, ConjugateMalawiNasopharynxHealthy Volunteers

Stichwörter der Autor:innen

Africahuman challenge modelpneumococcal carriagepneumococcusvaccine efficacy

Substanzen

Pneumococcal Vaccines13-valent pneumococcal vaccineVaccines, Conjugate

Autor:innen und Institutionen

  • Malawi Liverpool Wellcome Programme, Blantyre.
  • Liverpool School of Tropical Medicine, United Kingdom.
  • Department of Medicine, Queen Elizabeth Central Hospital.
  • Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Department of Paediatrics, University of Oxford, Oxford, England.
  • Liverpool University Hospitals NHS Foundation Trust, United Kingdom.

ORCID-Profile: Bridgette Galafa, Tarsizio Chikaonda, Simon Sichone, Lusako Sibale, Dingase Dula, Edna Nsomba, Godwin Tembo, Anthony E Chirwa, Clara Ngoliwa, Neema Toto, Ashleigh Howard, Tinashe K Nyazika, John Ndaferankhande, Lorensio Chimgoneko, Ndaziona P K Banda, Gift Chiwala, Jamie Rylance, Daniela Ferreira, Kondwani C Jambo, Ben Morton, Marc Y R Henrion, Stephen B Gordon

Förderung

  • Wellcome Trust
  • Liverpool School of Tropical Medicine

Zitieren

APA

Galafa, B., Chikaonda, T., Kudowa, E., Sichone, S., Sibale, L., Thole, F., Mkandawire, C., Dula, D., Nsomba, E., Tembo, G., Chaponda, M., Chirwa, A. E., Nkhoma, V., Ngoliwa, C., Kamng'ona, R., Toto, N., Makhaza, L., Muyaya, A., Howard, A., …, & Gordon, S. B. (2025). Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge Model. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae341

Vancouver

Galafa B, Chikaonda T, Kudowa E, Sichone S, Sibale L, Thole F, et al. Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge Model. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae341

BibTeX
@article{Galafa2025,
  author = {Galafa, Bridgette and Chikaonda, Tarsizio and Kudowa, Evaristar and Sichone, Simon and Sibale, Lusako and Thole, Faith and Mkandawire, Christopher and Dula, Dingase and Nsomba, Edna and Tembo, Godwin and Chaponda, Mphatso and Chirwa, Anthony E and Nkhoma, Vitumbiko and Ngoliwa, Clara and Kamng'ona, Raphael and Toto, Neema and Makhaza, Lumbani and Muyaya, Alfred and Howard, Ashleigh and Nyazika, Tinashe K and Ndaferankhande, John and Chimgoneko, Lorensio and Banda, Ndaziona P K and Chiwala, Gift and Rylance, Jamie and Ferreira, Daniela and Jambo, Kondwani C and Morton, Ben and Henrion, Marc Y R and Gordon, Stephen B},
  title = {Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge Model},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiae341}
}
Kostenlos starten →